Fintel on MSN23h
Leerink Partners Initiates Coverage of Zura Bio (ZURA) with Outperform Recommendation
Fintel reports that on November 4, 2024, Leerink Partners initiated coverage of Zura Bio (NasdaqCM:ZURA) with a Outperform ...
Molecular Partners’ Promising Pipeline and Financial Stability Justify Buy Rating
In a report released on November 1, Jonathan Chang from Leerink Partners reiterated a Buy rating on Molecular Partners (MOLN – Research ...
fintechmagazine5d
Leerink: The Company That Bounced Back from an SVB Demerger
Leerink Partners CIO Jeff Gerson on how the firm realigned its technology strategies and services after it demerged from SVB ...
fintechmagazine5d
Jeff Gerson
Leerink Partners CIO Jeff Gerson on how the firm realigned its technology strategies and services after it demerged from SVB ...
bovnews3h
Stock Shock: The Unpredictable Rise and Fall of NVST—What’s Driving the Drama?
On Monday, Envista Holdings Corp (NVST) stock saw a modest uptick, ending the day at $21.28 which represents a slight increase of $0.34 or 1.62% from the prior close of $20.94. The stock opened at $21 ...
Yahoo Finance4d
Tom Davidson Joins Leerink Partners as Co-President and Co-Head of Global Investment Banking
BOSTON, Nov. 1, 2024 /PRNewswire/ -- Leerink Partners, a leading investment bank specializing in healthcare, is pleased to announce that Tom Davidson has joined as Co-President of the firm and Co ...
bovnews1d
Leerink Partners Just Upgraded Gilead Sciences, Inc. (GILD) Stock—What Does This Mean for Investors?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.21% of ...
Merus’s Buy Rating Justified Despite PDUFA Extension: Confidence in Pipeline and Partnerships
In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on Merus (MRUS – Research Report), with a price ...
Nasdaq14d
Leerink Partners Upgrades Envista Holdings (NVST)
Fintel reports that on October 31, 2024, Leerink Partners upgraded their outlook for Envista Holdings (NYSE:NVST) from Underperform to Market Perform. As of October 22, 2024, the average one-year ...
Investing3d
Leerink keeps Outperform rating on Merck as Gardasil concerns weighing on stock
On Friday, Leerink Partners maintained an Outperform rating on shares of Merck & Co., Inc. (NYSE:MRK), citing ongoing concerns about the pharmaceutical giant's Gardasil vaccine as a key factor ...
Investing3d
Leerink keeps Outperform rating on Merck as Gardasil concerns weighing on stock
On Friday, Leerink Partners maintained an Outperform rating on shares of Merck & Co., Inc. (NYSE:MRK), citing ongoing concerns about the pharmaceutical giant's Gardasil vaccine as a key factor ...